Single-cell and spatial omics reveals region-specific plasticity and therapeutic vulnerabilities in metastatic high-risk neuroblastoma
Science Advances · 17.07.2026 · 12 (29)
DOI: 10.1126/sciadv.aec6749 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 17.07.2026. Verfasst von Lai Man Natalie Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Hematology and Cancer Biology, Brain Tumor Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. Hauptthemen laut MEDLINE: Neuroblastoma, Single-Cell Analysis. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, National Institutes of Health, U.S. Department of Defense.
Abstract (Originalsprache)
Neuroblastoma, a pediatric cancer derived from sympathetic ganglia of the peripheral nervous system, frequently metastasizes, driving poor outcomes. Primary neuroblastomas are well-characterized, but the mechanisms underlying metastasis remain poorly understood. Here, by using single-cell and spatial multiomics, we identified that lymph node metastases in high-risk neuroblastomas display distinctive cellular heterogeneity and plasticity, marked by mesenchymal-like and stem-like states and heightened epithelial-to-mesenchymal transition activity compared to primary adrenal tumors. In addition, compared to primary adrenal masses, the metastatic niche display increased immunosuppressive myeloid programs, heightened immune checkpoint signaling, and lymphocyte exhaustion, which are indicative of immune evasion and dysfunction. Notably, metastatic neuroblastomas show elevated eIF4F translation machinery and XPO1 levels. Dual inhibition of eIF4A and XPO1 synergistically halted tumor growth and prolonged survival in xenograft models. Together, our multiomics studies reveal the molecular and cellular plasticity that contributes to therapy resistance and highlight exploitable therapeutic vulnerabilities in high-risk metastatic neuroblastomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Experimental Hematology and Cancer Biology, Brain Tumor Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
- Medpace Inc., Cincinnati, OH 45227, USA.
- Center for Childhood Cancer, Abigail Wexner Research Institute, Nationwide Children's Hospital and Department of Pediatrics, The Ohio State University, Columbus, OH 43215, USA.
- Division of Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
- Riley Children's Health, Pediatric Cancer and Blood Disorders, Indiana University MSA Indianapolis, IN 46202, USA.
- Department of Pediatrics, O'Neal Comprehensive Cancer Center, Marnix E. Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35233-1771, USA.
ORCID-Profile: Lai Man Natalie Wu, Janet L Oblinger, Feng Zhang, Mike Adam, Sara Szabo, Brian D Weiss, Qing Richard Lu
Förderung
- NINDS NIH HHS
- National Institutes of Health
- U.S. Department of Defense
- CancerFree KIDS
Zitieren
APA
Wu, L. M. N., Oblinger, J. L., Xin, D., Rao, R., Zhang, F., Adam, M., Lopez-Nunez, O., Szabo, S., von Allmen, D., Chang, L. S., Weiss, B. D., & Lu, Q. R. (2026). Single-cell and spatial omics reveals region-specific plasticity and therapeutic vulnerabilities in metastatic high-risk neuroblastoma. Science Advances, 12(29). https://doi.org/10.1126/sciadv.aec6749
Vancouver
Wu LMN, Oblinger JL, Xin D, Rao R, Zhang F, Adam M, et al. Single-cell and spatial omics reveals region-specific plasticity and therapeutic vulnerabilities in metastatic high-risk neuroblastoma. Science Advances. 2026;12(29). doi:10.1126/sciadv.aec6749
BibTeX
@article{Wu2026,
author = {Wu, Lai Man Natalie and Oblinger, Janet L and Xin, Dazhuan and Rao, Rohit and Zhang, Feng and Adam, Mike and Lopez-Nunez, Oscar and Szabo, Sara and von Allmen, Daniel and Chang, Long-Sheng and Weiss, Brian D and Lu, Qing Richard},
title = {Single-cell and spatial omics reveals region-specific plasticity and therapeutic vulnerabilities in metastatic high-risk neuroblastoma},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {29},
doi = {10.1126/sciadv.aec6749}
}
EUVIMED